ArticleCardio-oncology (London, England)2025

SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial.

A Greco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.